Thursday, June 14, 2018 10:24:20 AM
Mon May 14, 2018 6:00 AM|GlobeNewswire|About: IDVV
TEMECULA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation, a Medical Marijuana IP Holdings Company, today announces that the Company has received an investment commitment of $500,000 from its strategic partner Voltage River (www.voltageriver.com).
The capital injection will be used primarily for expanding the production of the Company’s newest product line, the OGGL—The Off Grid Grow Lab. Additionally, funds will be used to build out the Company’s infrastructure to support its long-term strategies.
Corporate Update
International Endeavors Corporation is in the process of locating and acquiring land and properties in the Cannabis friendly areas of Northern and Southern California. The Company portfolio includes commercial and agricultural land and buildings. As well, the Company owns and leases upscale recreational vehicle lots in the wine country of Southern California.
About International Endeavors Corporation
International Endeavors Corporation is a company focused on building IP in the Medical Marijuana Sector through the creation of biomedical devices, clean energy and patents. www.internationalendeavorscorp.com
Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Nate Engel
CEO
Phone: 951-296-1024
Email: nate@internationalendeavorscorp.com
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM